12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Aeolus preclinical data

In rats, subcutaneous AEOL 10150 following sulfur mustard gas exposure significantly improved survival by up to 82% over 48 hours after exposure vs. saline-treated controls. AEOL 10150 also improved pulse oximetry (p<0.0001), reduced clinical scores of respiratory quality and activity by >60% at 48 hours (p<0.005) and reduced airway cast formation by 50% at 24 hours (p<0.017) vs. controls. Separately, subcutaneous and topical treatment with AEOL 10150...

Read the full 311 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >